Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis.
2000Journal of gastroenterology and hepatology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.
2005Journal of clinical microbiology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis.
2006Journal of medical microbiology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.
2008International journal of medical microbiology : IJMM
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.
2010BMC gastroenterology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.
2016International journal of colorectal disease
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Increased Enterococcus faecalis infection is associated with clinically active Crohn disease.
2016Medicine
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.
2019Cell host & microbe
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment.
2019Cell death & disease
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
2019Journal of digestive diseases
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial.
2020Trials
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.
2020Trials
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Capsular Polysaccharide From Bacteroides fragilis Protects Against Ulcerative Colitis in an Undegraded Form.
2020Frontiers in pharmacology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation.
2021BMC microbiology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Intestinal flora alterations in patients with ulcerative colitis and their association with inflammation.
2021Experimental and therapeutic medicine
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Long-Term Efficacy of Low-Intensity Single Donor Fecal Microbiota Transplantation in Ulcerative Colitis and Outcome-Specific Gut Bacteria.
2021Frontiers in microbiology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity.
2022Nature microbiology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Identification of gut microbiome and transcriptome changes in ulcerative colitis and pouchitis.
2022Scandinavian journal of gastroenterology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Impact of gut Microbiome alteration in Ulcerative Colitis patients on disease severity and outcome.
2023Clinical and experimental medicine
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Bacterial Oncotraits Rather than Spatial Organization Are Associated with Dysplasia in Ulcerative Colitis.
2023Journal of Crohn's & colitis
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Dynamics of the Gut Mycobiome in Patients With Ulcerative Colitis.
2024Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning.
2024Gut microbes
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Microbially catalyzed conjugation of GABA and tyramine to bile acids.
2024Journal of bacteriology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Berberine regulates intestinal microbiome and metabolism homeostasis to treat ulcerative colitis.
2024Life sciences
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Comparison of microbial communities and the profile of sulfate-reducing bacteria in patients with ulcerative colitis and their association with bowel diseases: a pilot study.
2024Microbial cell (Graz, Austria)
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease.
2024International journal of molecular sciences
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Core microbiome-associated proteins associated with ulcerative colitis interact with cytokines for synergistic or antagonistic effects on gut bacteria.
2024The ISME journal
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Sustained mucosal colonization and fecal metabolic dysfunction by Bacteroides associates with fecal microbial transplant failure in ulcerative colitis patients.
2024Scientific reports
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Alterations of the Gut Microbiome and TMAO Levels in Patients with Ulcerative Colitis.
2024Journal of clinical medicine
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Differential contributions of the gut microbiota and metabolome to pathomechanisms in ulcerative colitis: an in vitro analysis.
2024Gut microbes
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Changes in amino acid concentrations and the gut microbiota composition are implicated in the mucosal healing of ulcerative colitis and can be used as noninvasive diagnostic biomarkers.
2024Clinical proteomics
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Patient-donor similarity and donor-derived species contribute to the outcome of fecal microbiota transplantation for ulcerative colitis.
2025Journal of Crohn's & colitis
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Mitigation of chemotherapy-induced gut dysbiosis and diarrhea by supplementation with heat-killed Bacteroides fragilis.
2025BMC medicine
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Environmental factors drive bacterial degradation of gastrointestinal mucus.
2025NPJ biofilms and microbiomes
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Detection of tissue colonizing bacteria and their association with clinicopathological and molecular features of inflammatory bowel disease.
2025Journal of translational medicine
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
